Decreased β-cell function in a case with Becker muscular dystrophy accompanied by post-transplant diabetes

Area of Science:

• Endocrinology
• Genetics
• Metabolic Disorders

Background:

• Duchenne and Becker muscular dystrophy (DMD/BMD) are genetic disorders causing progressive muscle degeneration and impaired glucose metabolism.
• Skeletal muscle dysfunction in DMD/BMD affects insulin sensitivity and glucose uptake, potentially leading to systemic glucose intolerance.

Purpose of the Study:

• To investigate the development of diabetes in a patient with Becker muscular dystrophy (BMD) following heart transplantation and immunosuppressive therapy.
• To explore the role of beta-cell function in glucose intolerance among individuals with DMD/BMD, particularly in the context of increased insulin demand.

Main Methods:

• Case study of a 25-year-old man with BMD who developed diabetes post-heart transplantation.
• Comparative analysis of glucose tolerance and beta-cell function between the patient and his older brother with BMD (untransplanted).

Main Results:

• The patient with BMD developed diabetes post-immunosuppression, exhibiting decreased beta-cell function.
• His brother with BMD, without transplantation, showed only mild glucose intolerance and preserved beta-cell function.
• These findings underscore the significant impact of beta-cell dysfunction on diabetes development in DMD/BMD.

Conclusions:

• Beta-cell dysfunction is critical for diabetes development in individuals with DMD/BMD experiencing increased insulin demands.
• Vigilance for post-transplant diabetes is crucial in BMD patients receiving immunosuppressive agents.